Target intelligence / Profile preview

Long intergenic non-protein coding RNA 152 (CYTOR (alternatively LINC00152))

Target
CYTOR (alternatively LINC00152)
Molecular classification
Long non-coding RNA (lncRNA), Competing endogenous RNA (ceRNA), Other (epigenetic modulator)
01

Overview

CYTOR (LINC00152) is a long non-coding RNA (lncRNA), approximately 828–852 base pairs, located on human chromosome 2p11.2, primarily expressed in the cytoplasm and occasionally in the nucleus. CYTOR acts as a competitive endogenous RNA (ceRNA), sponging microRNAs and interacting with chromatin-modifying complexes such as PRC2, thus regulating a wide variety of downstream genes and pathways critical for tumor progression, cell proliferation, invasion, EMT, and therapy resistance. It is overexpressed in many cancers and correlated with tumor aggressiveness and poor outcomes, serving as a promising biomarker and a potential (experimental) therapeutic target; no drugs are approved to target it, but antisense and RNA interference modalities are under investigation. Its incomplete conservation in model organisms presents challenges for translational research and therapeutic development.

Other names
CYTORLINC00152C2orf59NCRNA00152MGC4677Long intergenic non-protein coding RNA 152STAiR18
02

Mechanism of action

If targeted by drugs (e.g., by antisense oligonucleotides), mechanisms would chiefly involve: Inhibition of lncRNA function (e.g., interference with ceRNA/miRNA sponging, disruption of epigenetic modulation)

03

Biological functions

Cell proliferationCell cycle regulationApoptosisMigrationInvasionEpithelial-mesenchymal transition (EMT)Chemotherapy and radiotherapy resistanceRegulation of gene expression (epigenetic and post-transcriptional)Interaction with signaling pathways including NF-κB, Wnt/β-catenin, PI3K/AKT, Notch, EGFR, mTOR
04

Disease associations

Cancer (role demonstrated in many tumor types, including gastric, breast, ovarian, colorectal, hepatocellular, lung, gliomas, and others)InflammationVascular diseaseInfection (evidence in tuberculosis)Oral diseases
05

Safety considerations

Lack of cross-species conservation limits preclinical animal modelingMultiple transcript isoforms create challenges for specific targetingOff-target effects and delivery issues are potential concerns for RNA-targeting therapeutics
06

Interacting drugs

None currently approved or clinically available; various antisense/siRNA approaches in research. No small molecule or antibody drugs directly target CYTOR
07

Biomarkers

CYTOR/LINC00152 RNA expression (used diagnostically and prognostically in various cancers, especially for assessing tumor progression, metastasis, resistance to therapy, and patient prognosis)Associated biomarkers reported in context, e.g., CA19-9 for colorectal cancer

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 152 (CYTOR (alternatively LINC00152)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 152 (CYTOR (alternatively LINC00152)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call